Non-invasive Measurement of Hemoglobin in Infants and Neonates

Non-invasive Measurement of Hemoglobin in Infants and Neonates: Comparison With CO-oximetrie and Point-of-care Devices.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02655107

Enrollment

Registered

2016-01-13

Start date

2015-02-28

Completion date

2016-08-31

Last updated

2016-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoglobins

Keywords

blood gas monitoring, non-invasive, hemoglobin

Brief summary

Detailed description

Non-invasive measurement of hemoglobin in infants and neonates scheduled for elective congenital heart surgery, weighing between 3kg and 20 kg. SpHb measurement will be compared to the gold standard of hemoglobin measurement - CO-oximetrie - and to the point-of-care (GEM 3500 premiere). Data collection whenever an arterial blood gas analysis is indicated by the experienced attending anesthetist - before and after cardiopulmonary bypass.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to 2 Years

Healthy volunteers

Inclusion criteria

* scheduled for elective congenital heart surgery * routine use of an arterial line * weight \>= 3000g

Exclusion criteria

* urgent surgery * premature birth * parents refuse

Design outcomes

Primary

Measure	Time frame
Hemoglobin measurement non-invasively compared to gold standard hemoglobin	intraoperative

Countries

Germany

Outcome results